Arq. Bras. Oftalmol. 2018; 81 (5): 10.5935/0004-2749.20180079
Total: 1140
Luiz Guilherme Azevedo de Freitas1,2; David Leonardo Cruvinel Isaac1,3; Eliana Martins Lima4; Leonardo Gomes Souza4; Murilo Alves Abud1; Ricardo Gomes dos Reis1; William Thomas Tannure1; Marcos Pereira de Ávila1
DOI: 10.5935/0004-2749.20180079
1. Departamento de Retina e Vítreo, Universidade Federal de Goiás, Goiânia, GO, Brasil
2. Hospital de Olhos Santa Luzia, Recife, PE, Brasil
3. Hospital das Clínicas, Universidade Federal de Goiás, Goiânia, GO, Brasil
4. FarmaTec, Laboratório de Nanotecnologia Farmacêutica, Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia, GO, Brasil
Luiz Guilherme Azevedo de Freitas
Rua Estrada do Encanamento, 909
Recife, PE - 52060-000 - Brazil
E-mail: [email protected]
Funding: No specific financial support was available for this study
Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose
Approved by the following research ethics committee: Universidade Federal de Goiás (# 062/2011)
How to cite this article:
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
